Related Experiment Video
Updated: Feb 12, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer
Madhura Kulkarni1,2, Tuan Zea Tan1, Nurfarhanah Bte Syed Sulaiman1
1Cancer Science Institute, NUS, Singapore.
Abstract:
Hippo pathway target, YAP has emerged as an important player in solid tumor progression. Here, we identify RUNX1 and RUNX3 as novel negative regulators of oncogenic function of YAP in the context of breast cancer. RUNX proteins are one of the first transcription factors identified to interact with YAP. RUNX1 or RUNX3 expression abrogates YAP-mediated pro-tumorigenic properties of mammary epithelial cell lines in an interaction dependent manner. RUNX1 and RUNX3 inhibit YAP-mediated migration and stem-ness properties of mammary epithelial cell lines by co-regulating YAP-mediated gene expression. Analysis of whole genome expression profiles of breast cancer samples revealed significant co-relation between YAP-RUNX1/RUNX3 expression levels and survival outcomes of breast cancer patients. High RUNX1/RUNX3 expression proved protective towards YAP-dependent patient survival outcomes. High YAP in breast cancer patients' expression profiles co-related with EMT and stem-ness gene signature enrichment. High RUNX1/RUNX3 expression along with high YAP reflected lower enrichment of EMT and stem-ness signatures. This antagonistic activity of RUNX1 and RUNX3 towards oncogenic function of YAP identified in mammary epithelial cells as well as in breast cancer expression profiles gives a novel mechanistic insight into oncogene-tumor suppressor interplay in the context of breast cancer progression. The novel interplay between YAP, RUNX1 and RUNX3 and its significance in breast cancer progression can serve as a prognostic tool to predict cancer recurrence.
Insights
RUNX1 and RUNX3 suppress the oncogenic YAP protein in breast cancer. This interaction inhibits tumor progression and improves patient survival, offering a new prognostic tool for cancer recurrence.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The Hippo pathway effector, Yes-associated protein (YAP), is a key driver in solid tumor progression.
- Understanding YAP's regulatory mechanisms is crucial for developing targeted breast cancer therapies.
Purpose of the Study:
- To identify novel regulators of YAP's oncogenic function in breast cancer.
- To investigate the interplay between YAP, RUNX1, and RUNX3 in breast cancer progression and patient survival.
Main Methods:
- Investigated the interaction between RUNX proteins and YAP in mammary epithelial cell lines.
- Analyzed whole-genome expression profiles of breast cancer samples.
- Correlated YAP, RUNX1, and RUNX3 expression levels with patient survival outcomes and gene signatures (EMT, stemness).
Main Results:
- RUNX1 and RUNX3 were identified as novel negative regulators of YAP's oncogenic activity.
- RUNX1/RUNX3 expression abrogated YAP-mediated pro-tumorigenic properties, including migration and stemness.
- High RUNX1/RUNX3 expression correlated with better patient survival and reduced enrichment of EMT and stemness signatures, even with high YAP levels.
Conclusions:
- RUNX1 and RUNX3 antagonize YAP's oncogenic function in breast cancer, providing mechanistic insight into oncogene-tumor suppressor interplay.
- The YAP-RUNX1/RUNX3 interaction represents a potential prognostic tool for predicting breast cancer recurrence.
Related Concept Videos
Cancer Survival Analysis
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

